Stocks · Health care · Biological Products, (No Diagnostic Substances)

Acumen Pharmaceuticals, Inc.

ABOS Clue Score27

United States Fiscal year ends December CIK 0001576885 Results filed 26 Oct 2026

Add to watchlist

What the insiders did Net selling

By person

15 insiders · 48 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Derek M Meisner

Chief Legal Officer & Corp Sec

—

$248.89K (16)

−$248.89K

173,999

0.2406%

$404.55K

+59.8%

Daniel Joseph OConnell

Chief Executive Officer

—

$163.12K (8)

−$163.12K

881,275

1.22%

$2.05M

+75.4%

Derrell Porter

Director

—

$75.24K (3) scheduled

−$75.24K

35,500

0.0491%

$82.54K

—

Matt Zuga

CFO & Chief Business Officer

—

$49.56K (7)

−$49.56K

304,924

0.4216%

$708.95K

+44.2%

Russell Barton

Chief Operating Officer

—

$29.92K (6)

−$29.92K

205,092

0.2836%

$476.84K

+111.7%

Eric Siemers

Chief Medical Officer

—

$27.11K (4)

−$27.11K

255,371

0.3531%

$593.74K

+117.2%

James J. Doherty

President and CDO

—

$15.15K (2)

−$15.15K

220,900

0.3055%

$513.59K

—

Nathan B Fountain

Director

—

$14.27K (1)

−$14.27K

48,150

0.0666%

$111.95K

+670.4%

Amy Schacterle

Chief Regulatory Officer

—

$2.18K (1)

−$2.18K

92,303

0.1276%

$214.60K

—

John A Stalfort III

Director

—

—

—

220,624

0.3051%

$512.95K

+28.0%

Ra Capital Management, L.p. entity

Director

—

—

—

48,300

0.0668%

$112.30K

—

Kimberlee C Drapkin

Director

—

—

—

48,300

0.0668%

$112.30K

—

Laura Stoppel

Director

—

—

—

48,300

0.0668%

$112.30K

—

Jeffrey L. Ives

Director

—

—

—

48,300

0.0668%

$112.30K

—

George Golumbeski

Director

—

—

—

35,500

0.0491%

$82.54K

—